Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
The total investment is in the region of Rs 200 crore
Supply increase to help meet growing global demand
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Up to 100 million mRNA vaccine doses could be produced in Australia each year
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
